Oxurion NV
Biotechnology Research
Leuven, Vlaams Brabant, Be
35 employees
- Employees
- 35
- Contacts
- 3
- Emails
- 3
Oxurion NV Overview
- Headquarters
- Leuven, Vlaams Brabant, Be
- Website
- www.oxurion.com
- Industry
- Biotechnology Research
- Employees
- 35
- Funding
- 483.4K
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Oxurion NV
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven, Belgium, with corporate operations in Boston, MA. More information is available at www.oxurion.com.
Oxurion NV Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Oxurion NV Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Johny Van Genechten | Head of Global Ict at Thrombogenics Nv |
View
|
|
| Stijn Lagaert | Partner, European & Belgian Patent | Leuven, Flemish Region, Belgium |
Email
|
| Linda Knott | Office Manager at Thrombogenics, Inc. | Middlesex, New Jersey, United States |
Email
|
| Bert Tuerlinckx | Tessenderlo, Flemish Region, Belgium |
Email
|
Employees by Management Level
VP / Head
1 profile
Manager
1 profile
Individual contributor
1 profile
Compare Similar Companies to Oxurion NV
Ablynx
Biotechnology Research
Hopium
Fuel Cell Manufacturing
Confo Therapeutics
Biotechnology
EyeBio
Biotechnology Research
AstriVax Therapeutics
Biotechnology Research
Celyad Oncology
Biotechnology Research
Rewind Therapeutics
Biotechnology Research
Flamingo Therapeutics
Biotechnology Research
Breye Therapeutics ApS
Pharmaceutical Manufacturing
Findrive
Automotive